title: High prevalence of macrolide resistance: not in every country! [Comment on: Halpern et al. J Antimicrob Chemother 2005; 55: 748-57].
authors.forename: Dominique L
authors.initials: DL
authors.lastname: Monnet
authors.forename: Christian T
authors.initials: CT
authors.lastname: Brandt
authors.forename: Margit S
authors.initials: MS
authors.lastname: Kaltoft
authors.forename: Line
authors.initials: L
authors.lastname: Bagger-Skjøt
authors.forename: Thomas L
authors.initials: TL
authors.lastname: Sørensen
authors.forename: Hans-Ulrik K
authors.initials: HU
authors.lastname: Nielsen
authors.forename: Niels
authors.initials: N
authors.lastname: Frimodt-Møller
mesh_terms: D000900:Anti-Bacterial Agents / Q000494:pharmacology* / Q000627:therapeutic use; D024881:Drug Resistance, Bacterial; D005060:Europe / Q000453:epidemiology; D006801:Humans; D018942:Macrolides / Q000494:pharmacology* / Q000627:therapeutic use; D015201:Meta-Analysis as Topic; D015995:Prevalence
chemical_list: D000900:Anti-Bacterial Agents; D018942:Macrolides